09/10/2025 13:21
INNORNA Completes Phase II Enrollment and Vaccination of Bivalent RSV mRNA Vaccine IN006

Innorna today announced the completion of enrollment and vaccination in its Phase II clinical trial for IN006, the world’s first bivalent respiratory syncytial virus (RSV) mRNA vaccine currently in development by the company. IN006 is also China's first domestically developed RSV vaccine to enter clinical trials, following IND approval in June 2024. The Phase I trial began with the first subject vaccinated in November 2024. Completion of enrollment and dosing in Phase II marks a milestone tow...

09/11/2025 20:39
Mirion to Join the U.S. Industry Program at the 69th IAEA General Conference in Vienna, Austria

Mirion, a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, is honored to announce its invitation to attend the 69th International Atomic Energy Agency (IAEA) General Conference. Scheduled for September 15–19 in Vienna, Austria, this annual event brings together key stakeholders from across the globe to discuss issues critical to nuclear safety, security, and peaceful applications of nuclear techno...

AFP to Participate in Media Literacy Week Conference with the Lakmusz-HDMO Project for International Fact-Checking Day

AFP, alongside its partners in the Lakmusz-HDMO project—an initiative funded by the European Union to combat disinformation—is participating in a week-long event in Budapest to mark International Fact-Checking Day on 2 April 2025.

AFP, alongside its partners in the Lakmusz-HDMO project—an initiative funded by the European Union to combat disinformation—is participating in a week-long event in Budapest to mark International Fact-Checking Day on 2 April 2025.
07/16/2025 17:35
Nanochon Announces Health Canada Approval for First in Human Investigation

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada Approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with Sports Medicine Specialists, Drs. Joel Lobo, Kajeandra Ravichandiran and Marcin Kowalczuk as Sub-Investigators, at the Durham Bone &a...

09/09/2025 00:00
Trilliant Accelerates Advanced Metering Infrastructure Deployments Across the Asia-Pacific Region

Trilliant, a leading international provider of solutions for advanced metering infrastructure (AMI), smart grid, smart cities and IIoT, continues to focus on enabling utilities and energy organizations in Asia-Pacific (APAC) with more than 13 million smart meters operational or in deployment in the region, and millions more planned through strategic partnerships in areas such as Thailand, Malaysia, Philippines, Indonesia, Japan and India. This latest milestone highlights Trilliant’s commitmen...

07/24/2025 11:50
Continuous Protection for the Cloud Era: Veracode Spotlights Latest Innovations for Advanced Software Security

Veracode, a global leader in application risk management, today unveiled a suite of innovations that transform how enterprises approach security. The enhanced platform cuts vulnerability remediation time by up to 92 percent, while using proactive defense to prevent 60 percent of critical supply chain risk from ever entering organizations. These latest enhancements to Veracode’s Package Firewall and Risk Manager provide assurance, context, and continuity across the software development lifecycle...